Advertisement

Topics

Lupin net falls sharply by 59% to Rs.358 cr in Q1

08:15 EDT 5 Aug 2017 | PharmaBiz

Lupin, the second largest pharma company in India with net sales of Rs.17,100 crore plus, has received major setback during the first quarter ended June 2017 on account of lower sales in US and India. Its

Original Article: Lupin net falls sharply by 59% to Rs.358 cr in Q1

NEXT ARTICLE

More From BioPortfolio on "Lupin net falls sharply by 59% to Rs.358 cr in Q1"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...